Newsletter Signup | Join Community | Cancer Types
Leading cancer centers create combined social community with MPNRF PV Reporter & Cancer Connect to support MPN patients
Apr 13, 2019
AML drug Daurismo evaluated in MF - further study warranted.
Apr 2, 2019
Thalidomide - Jakafi Combination may be Effective for Treatment of Myelofibrosis Associated Low Blood Counts
Feb 22, 2019
Researchers evaluate combining Interferon and Jakafi as primary treatment for Myelofibrosis
Jan 31, 2019
Resources for second opinions and where to get them for PV, ET and MF
Nov 27, 2018
Stay current with MPN treatment advances and connect with others.
Nov 15, 2018
Essential Thrombocythemia, treatment and advances
Sep 28, 2018
Understanding Myeloproliferative Neoplasms: Polycythemia vere, essential thrombocythemia, and myelofibrosis.
Spleenomegaly from Myelofibrosis Improved with Jakafi
The PV Tracker helps patients effectively monitor their symptoms and manager their condition.
Sep 25, 2018
Myeloproliferative Neoplasm itching explained by David Wallace of the PV Reporter
Sep 24, 2018
If you have been diagnosed with myelofibrosis or polycythemia vera, you may have experienced itching as a side effect
Sep 5, 2018
Myeloproliferative Neoplasms Greatly Affect Patient Quality of Life.
Aug 1, 2018
Looking for individuals to participate in research studies.
Jul 4, 2018
Research Suggests JAK Inhibitors May Cause Aggressive Lymphoma
Jun 18, 2018
Incyte Announces Initiation of Clinical Trial Evaluating Jakafi® for the Treatment of Essential Thrombocythemia.
Nov 22, 2017
All Symptomatic Polycythemia Vera Patients May Benefit From Treatment with a JAK2 Inhibitor.
Dec 29, 2015
International Marrow Donor Registries Reach 25 Million Potential Donors, Give Hope to Searching Blood Cancer Patients
Apr 1, 2015
Jan 6, 2015
Dec 11, 2014
Jakafi: First Drug Approved for Treatment of Polycythemia Vera
Dec 5, 2014
Jakafi® (ruxolitinib) Product Label Expanded to Include Overall Survival Data and Additional Safety and Dosing Info
Jul 30, 2014
Jak2, CALR, Gene Mutation Identified in Myeloproliferative Neoplasms
Dec 31, 2013
Health behaviors & medical history may affect the likelihood of developing polycythemia vera & essential thrombocythemia
Dec 5, 2013
Jan 24, 2019
Is it worth going to someone who specializes in the treatment of MPNs like PV MF or ET?
Oct 9, 2018
MF - ELZONRISTM (tagraxofusp; SL-401) trials in MF look promising: https://ir.stemline…
Sep 4, 2018
Read the news update about the risk of lymphoma with treatment; has anyone's doctor discussed t...